| Systematic (IUPAC) name | |
|---|---|
| 17b-hydroxy-17a-methylandrost-4-ene-3-one | |
| Clinical data | |
| Trade names | Virilon |
| AHFS/Drugs.com | monograph |
| Pregnancy cat. | ? |
| Legal status | Schedule III (US) |
| Routes | oral |
| Pharmacokinetic data | |
| Metabolism | Liver |
| Half-life | 6-8 hours |
| Excretion | 90% urine / 10% feces |
| Identifiers | |
| CAS number | 58-18-4 |
| ATC code | G03BA02 |
| PubChem | CID 6010 |
| DrugBank | DB06710 |
| ChemSpider | 5788 |
| UNII | V9EFU16ZIF |
| ChEBI | CHEBI:27436 |
| ChEMBL | CHEMBL1395 |
| Chemical data | |
| Formula | C20H30O2 |
| Mol. mass | 302.451 |
| SMILES | eMolecules & PubChem |
|
|
| (what is this?) (verify) |
|
Methyltestosterone (brand names:[1] Android, Testred, Virilon) is a 17-alpha-alkylated anabolic steroid used to treat men with a testosterone deficiency.[2] It is also used in women to treat breast cancer, breast pain, swelling due to pregnancy, and with the addition of estrogen it can treat symptoms of menopause. It bears close structural similarity to testosterone, but has a methyl group at C17 in order to increase oral bioavailability.
|
|||||||||||||||||||||||||||